Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Mar;53(3):295-297.
doi: 10.1016/j.dld.2020.10.021. Epub 2020 Oct 19.

Fecal calprotectin levels in COVID-19: Lessons from a systematic review on its use in inflammatory bowel disease during the pandemic

Anuraag Jena  1 , Praveen Kumar-M  1 , Anupam Kumar Singh  1 , Vishal Sharma  2
Affiliations
Comment

Fecal calprotectin levels in COVID-19: Lessons from a systematic review on its use in inflammatory bowel disease during the pandemic

Anuraag Jena et al. Dig Liver Dis. 2021 Mar.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare that they have no conflicts of interest.

Figures

Fig. 1
Fig. 1
Image showing the frequency of elevated fecal calprotectin in patients with COVID-19.
See this image and copyright information in PMC

Comment on

  • COVID-19 and intestinal inflammation: Role of fecal calprotectin.
    Ojetti V, Saviano A, Covino M, Acampora N, Troiani E, Franceschi F; GEMELLI AGAINST COVID‐19 group. Ojetti V, et al. Dig Liver Dis. 2020 Nov;52(11):1231-1233. doi: 10.1016/j.dld.2020.09.015. Epub 2020 Sep 22. Dig Liver Dis. 2020. PMID: 33060042 Free PMC article. No abstract available.

References

    1. Colombel J.F., Panaccione R., Bossuyt P., Lukas M., Baert F., Vaňásek T. Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial. Lancet. 2018 Dec 23;390(10114):2779–2789. - PubMed
    1. Kim Y.H. Home-based fecal calprotectin test is expected to play an important role in patients with inflammatory bowel diseases. Intest Res. 2018;16(4):507–508. - PMC - PubMed
    1. Iacucci M., Cannatelli R., Labarile N., Mao R., Panaccione R., Danese S., Kochhar G.S., Ghosh S., Shen B. Endoscopy in inflammatory bowel diseases during the COVID-19 pandemic and post-pandemic period. Lancet Gastroenterol Hepatol. 2020;5(6):598–606. - PMC - PubMed
    1. Effenberger M., Grabherr F., Mayr L., Schwaerzler J., Nairz M., Seifert M., Hilbe R., Seiwald S., Scholl-Buergi S., Fritsche G., Bellmann-Weiler R., Weiss G., Müller T., Adolph T.E., Tilg H. Faecal calprotectin indicates intestinal inflammation in COVID-19. Gut. 2020;69(8):1543–1544. - PMC - PubMed
    1. Britton G.J., Chen-Liaw A., Cossarini F., Livanos A.E., Spindler M.P., Plitt T., Eggers J., Mogno I., Gonzalez-Reiche A., Siu S., Tankelevich M., Grinspan L., Dixon R.E., Jha D., Martinez-Delgado G., Amanat F., Hoagland D.A., tenOever B., Dubinsky M.C., Merad M., van Bakel H., Krammer F., Bongers G., Mehandru S., Faith J.J. SARS-CoV-2-specific IgA and limited inflammatory cytokines are present in the stool of select patients with acute COVID-19. medRxiv [Preprint]. 2020 Sep 5:2020.09.03.20183947. doi: 10.1101/2020.09.03.20183947. PMID: 32909002; PMCID: PMC7480054.

Substances